busulfan has been researched along with Thrombocythemia in 62 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "The efficacy of hydroxyurea (HU) in myeloproliferative disorders is well documented." | 7.73 | Safety profile of hydroxyurea in the treatment of patients with Philadelphia-negative chronic myeloproliferative disorders. ( Fabris, F; Girolami, A; Luzzatto, G; Randi, ML; Ruzzon, E; Tezza, F, 2005) |
| "The case of a 48-year-old woman in whom focal nodular hyperplasia of the liver developed after busulfan therapy was administered for essential thrombocytosis is described." | 7.73 | Focal nodular hyperplasia after busulfan treatment. ( Aldi, M; Bedeschi, E; Bernardi, M; D'Errico, A; Emiliani, F; Foschi, FG; Girelli, F; Marano, G; Musardo, G; Savini, P; Stefanini, GF, 2005) |
| "The effect of busulfan therapy on the activity of oncornavirus-like particles and chromosome patterns in patients with polycythemia vera and essential thrombocythemia was studied." | 7.65 | Effect of busulfan on oncornavirus-like activity in platelets and chromosomes in polycythemia vera and essential thrombocythemia. ( Brodsky, I; Erlick, BJ; Fuscaldo, AA; Fuscaldo, KE, 1977) |
| "The effect of hydroxyurea in 35 patients with chronic granulocytic leukemia (CGL), who either had entered an accelerated phase of the disease or had experienced excessive myelosuppression following alkylating agents, was studied." | 7.65 | Hydroxyurea in the management of the hematologic complications of chronic granulocytic leukemia. ( Cannellos, GP; Schwartz, JH, 1975) |
| "Over a 19-year period, a patient with polycythemia vera who had undergone a splenectomy received six courses of busulfan for recurrent thrombocytosis." | 7.65 | Erythroleukemia-like syndrome due to busulfan toxicity in polycythemia vera. ( Kim, HC; Lindenbaum, J; Pezzimenti, JF, 1976) |
| "The efficacy of hydroxyurea (HU) in myeloproliferative disorders is well documented." | 3.73 | Safety profile of hydroxyurea in the treatment of patients with Philadelphia-negative chronic myeloproliferative disorders. ( Fabris, F; Girolami, A; Luzzatto, G; Randi, ML; Ruzzon, E; Tezza, F, 2005) |
| "The case of a 48-year-old woman in whom focal nodular hyperplasia of the liver developed after busulfan therapy was administered for essential thrombocytosis is described." | 3.73 | Focal nodular hyperplasia after busulfan treatment. ( Aldi, M; Bedeschi, E; Bernardi, M; D'Errico, A; Emiliani, F; Foschi, FG; Girelli, F; Marano, G; Musardo, G; Savini, P; Stefanini, GF, 2005) |
| "The effect of busulfan therapy on the activity of oncornavirus-like particles and chromosome patterns in patients with polycythemia vera and essential thrombocythemia was studied." | 3.65 | Effect of busulfan on oncornavirus-like activity in platelets and chromosomes in polycythemia vera and essential thrombocythemia. ( Brodsky, I; Erlick, BJ; Fuscaldo, AA; Fuscaldo, KE, 1977) |
| "The effect of hydroxyurea in 35 patients with chronic granulocytic leukemia (CGL), who either had entered an accelerated phase of the disease or had experienced excessive myelosuppression following alkylating agents, was studied." | 3.65 | Hydroxyurea in the management of the hematologic complications of chronic granulocytic leukemia. ( Cannellos, GP; Schwartz, JH, 1975) |
| "Over a 19-year period, a patient with polycythemia vera who had undergone a splenectomy received six courses of busulfan for recurrent thrombocytosis." | 3.65 | Erythroleukemia-like syndrome due to busulfan toxicity in polycythemia vera. ( Kim, HC; Lindenbaum, J; Pezzimenti, JF, 1976) |
| "The principal risks of essential thrombocythemia include thrombosis, major hemorrhage, and conversion to leukemia or myelofibrosis." | 2.41 | Therapeutic options for essential thrombocythemia and polycythemia vera. ( Solberg, LA, 2002) |
| "Erythromelalgia was localized in the forefoot sole and toes in 28, the fingertips in 9, the handpalm in 2." | 2.39 | Erythromelalgic, thrombotic and hemorrhagic manifestations in 50 cases of thrombocythemia. ( Lindemans, J; Michiels, JJ; van Genderen, PJ; van Vliet, HH, 1996) |
| "Erythrocytosis is not a feature of essential thrombocythemia (ET); this is the most important difference between ET and polycythemia vera (PV)." | 1.30 | Development of erythrocytosis in the course of essential thrombocythemia. ( Anttila, P; Ikkala, E; Jantunen, R; Juvonen, E; Oksanen, K; Ruutu, T, 1999) |
| "The 61 observations of primary thrombocythemia described in this report represent approximately 15% of the cases of polycythemia vera recorded by the authors over the same 18-year period." | 1.27 | [Essential thrombocythemia. Clinical, biological study and developmental study of 61 cases]. ( Bauters, F; Demory, JL; Huart, JJ; Jouet, JP; Simon, M, 1984) |
| "14 patients with essential thrombocythemia (ET) and 1 patient with agnogenic myeloid metaplasia received (1-(2-chloroethyl)-cyclohexyl-nitrosourea (CCNU), 80 mg/m2, p." | 1.27 | 1-(2-Chloroethyl)-cyclohexyl-nitrosourea-induced remission in essential thrombocythemia. ( Grossi, A; Leoni, F; Rossi Ferrini, P, 1983) |
| "Busulfan has been the drug most widely used during pregnancy, and it appears not to cause fetal malformations when used alone." | 1.26 | Chronic myelocytic leukemia and the myeloproliferative diseases during the child-bearing years. ( Miller, JB, 1976) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 49 (79.03) | 18.7374 |
| 1990's | 8 (12.90) | 18.2507 |
| 2000's | 4 (6.45) | 29.6817 |
| 2010's | 1 (1.61) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barrett, A | 1 |
| Catherwood, M | 1 |
| Thornton, P | 1 |
| Murphy, P | 1 |
| Quinn, J | 1 |
| Michiels, JJ | 2 |
| Berneman, Z | 1 |
| Schroyens, W | 1 |
| van Urk, H | 1 |
| MARCHAL, G | 1 |
| DUHAMEL, G | 1 |
| LEROUX, M | 1 |
| CHENDEROVITCH, J | 1 |
| GOGLIN, G | 1 |
| OUGIER, J | 1 |
| PAGE, G | 1 |
| MENGUS, C | 1 |
| CAMPANALE, RP | 1 |
| BARBIERI, U | 1 |
| ASCARI, E | 1 |
| GOBBI, F | 1 |
| KYLE, RA | 1 |
| BOWIE, EJ | 1 |
| BRUNSTING, LA | 1 |
| LEVITSKAIA, SV | 1 |
| BORODULINA, VI | 1 |
| Randi, ML | 1 |
| Ruzzon, E | 1 |
| Luzzatto, G | 1 |
| Tezza, F | 1 |
| Girolami, A | 1 |
| Fabris, F | 1 |
| Foschi, FG | 1 |
| Savini, P | 1 |
| Marano, G | 1 |
| Musardo, G | 1 |
| Bedeschi, E | 1 |
| Girelli, F | 1 |
| Emiliani, F | 1 |
| Aldi, M | 1 |
| D'Errico, A | 1 |
| Bernardi, M | 1 |
| Stefanini, GF | 1 |
| Fuscaldo, AA | 2 |
| Erlick, BJ | 2 |
| Brodsky, I | 3 |
| Fuscaldo, KE | 2 |
| Krug, K | 1 |
| Rohrberg, R | 1 |
| Wessel, H | 1 |
| Simon, M | 1 |
| Jouet, JP | 1 |
| Huart, JJ | 1 |
| Demory, JL | 1 |
| Bauters, F | 1 |
| Leoni, F | 1 |
| Grossi, A | 1 |
| Rossi Ferrini, P | 1 |
| Linker, H | 1 |
| Lindner, HJ | 1 |
| Reuter, H | 1 |
| Gross, R | 1 |
| Sceats, DJ | 1 |
| Baitlon, D | 1 |
| Woodruff, RK | 1 |
| Bell, WR | 1 |
| Castaldi, PA | 1 |
| Streatfield, K | 1 |
| Penington, DG | 1 |
| Brandt, L | 1 |
| Anderson, H | 1 |
| Baron, BW | 1 |
| Mick, R | 1 |
| Baron, JM | 1 |
| Tesselaar, ME | 1 |
| Wijermans, PW | 1 |
| Metsaars, JA | 1 |
| Gerrits, WB | 1 |
| Haak, HL | 1 |
| van Genderen, PJ | 1 |
| Lindemans, J | 1 |
| van Vliet, HH | 1 |
| Dapling, RB | 1 |
| Snowden, JA | 1 |
| West, J | 1 |
| Talbot, JF | 1 |
| Nelson, ME | 1 |
| Greaves, M | 1 |
| Kaaja, RJ | 1 |
| Leinonen, PJ | 1 |
| Jantunen, R | 1 |
| Juvonen, E | 1 |
| Ikkala, E | 1 |
| Oksanen, K | 1 |
| Anttila, P | 1 |
| Ruutu, T | 1 |
| Kuter, DJ | 1 |
| Solberg, LA | 1 |
| Semeraro, N | 1 |
| Cortellazzo, S | 1 |
| Colucci, M | 1 |
| Barbui, T | 1 |
| Singh, AK | 1 |
| Wetherley-Mein, G | 1 |
| Hussain, S | 1 |
| Walden, R | 1 |
| Adar, R | 1 |
| Mozes, M | 1 |
| Schwartz, JH | 1 |
| Cannellos, GP | 1 |
| Maurice, P | 1 |
| Miller, JB | 1 |
| Pezzimenti, JF | 1 |
| Kim, HC | 1 |
| Lindenbaum, J | 1 |
| MacEwen, EG | 1 |
| Drazner, FH | 1 |
| McClelland, AJ | 1 |
| Wilkins, RJ | 1 |
| Dullemond-Westland, AC | 1 |
| van Toorn, DW | 1 |
| Tsygankova, VA | 1 |
| Rudakov, IA | 1 |
| Bernadou, A | 1 |
| Clauvel, JP | 1 |
| Antebi, L | 1 |
| Bilski-Pasquier, G | 1 |
| Fickers, M | 1 |
| Speck, B | 1 |
| Lèques, B | 1 |
| Texier, L | 1 |
| Verdaguer, S | 1 |
| Hoffman-Martinot, R | 1 |
| Paulet, C | 1 |
| Moine, M | 1 |
| Lewis, SM | 1 |
| Szur, L | 1 |
| Inceman, S | 1 |
| Tangün, Y | 1 |
| Mason, JE | 1 |
| DeVita, VT | 1 |
| Canellos, GP | 1 |
| Kennedy, BJ | 1 |
| Harker, LA | 1 |
| Solhaug, JH | 1 |
| Martinez, J | 1 |
| Shapiro, SS | 1 |
| Holburn, RR | 1 |
| Clagett, GP | 1 |
| Thornbury, JR | 1 |
| Penner, JA | 1 |
| Dube, B | 1 |
| Bajpai, HS | 1 |
| Chawla, SC | 1 |
| Gupta, YN | 1 |
| Olesen, J | 1 |
| Videbaek, A | 1 |
| Robertson, JH | 2 |
| Clément, F | 1 |
| Saillen, R | 1 |
| Crozier, EH | 1 |
| Woodend, BE | 1 |
| Kahn, SB | 1 |
| Brady, LW | 1 |
| Morowitz, DA | 1 |
| Allen, LW | 1 |
| Kirsner, JB | 1 |
| Levine, J | 1 |
| Swanson, PD | 1 |
| Vodopick, H | 1 |
| Hamilton, HE | 1 |
| Jackson, HL | 1 |
| Peng, CT | 1 |
| Sheets, RF | 1 |
| Rodriguez-Erdmann, F | 1 |
| Goldberg, ME | 1 |
| Davey, F | 1 |
| Moloney, WC | 1 |
| Colman, RW | 1 |
| Sievers, CA | 1 |
| Pugh, RP | 1 |
| Cohen, I | 1 |
| Djaldetti, M | 1 |
| Karp, M | 1 |
| De Vries, A | 1 |
6 reviews available for busulfan and Thrombocythemia
| Article | Year |
|---|---|
Erythromelalgic, thrombotic and hemorrhagic manifestations in 50 cases of thrombocythemia.
Topics: Adult; Aged; Aspirin; Busulfan; Double-Blind Method; Erythromelalgia; Female; Gangrene; Hemorrhage; | 1996 |
The physiology of platelet production.
Topics: Animals; Blood Cell Count; Blood Platelets; Bone Marrow Cells; Busulfan; Cytokines; Humans; Megakary | 1996 |
Therapeutic options for essential thrombocythemia and polycythemia vera.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents; Aspirin; Busulfan; Fibrinolytic Agen | 2002 |
Disorders of hemostasis and thrombosis in the aged.
Topics: Adolescent; Adult; Aged; Aortic Aneurysm; Blood Coagulation Disorders; Blood Coagulation Factors; Bl | 1976 |
[Methods of studying blood thrombocytopoietic activity (literature review)].
Topics: Anemia; Animals; Blood Platelets; Blood Transfusion; Busulfan; Hemorrhage; Humans; Leukemia; Methods | 1972 |
Control of platelet production.
Topics: Androgens; Animals; Blood Platelets; Busulfan; Cell Nucleus; Cytoplasm; Diploidy; Erythropoietin; Es | 1974 |
1 trial available for busulfan and Thrombocythemia
| Article | Year |
|---|---|
Hydroxyurea therapy in chronic myelogenous leukemia.
Topics: Bone Marrow; Bone Marrow Cells; Busulfan; Clinical Trials as Topic; Drug Resistance; Humans; Hydroxy | 1972 |
55 other studies available for busulfan and Thrombocythemia
| Article | Year |
|---|---|
Transformation of MDS/MPN-RS-T to AML: Trisomy 13, resistant thrombocytosis and transient disease control with oral busulfan therapy.
Topics: Anemia, Sideroblastic; Busulfan; Humans; Leukemia, Myeloid, Acute; Myelodysplastic Syndromes; Thromb | 2018 |
Aspirin-responsive painful red, blue, black toe, or finger syndrome in polycythemia vera associated with thrombocythemia.
Topics: Aged; Aspirin; Busulfan; Erythromelalgia; Female; Fingers; Hematocrit; Humans; Male; Middle Aged; Pl | 2003 |
[Two cases of myeloid splenomegaly with hemorrhagiparous thrombocythemia; effects of myleran, importance of thromboelastograms].
Topics: Blood Platelets; Busulfan; Humans; Osteolysis, Essential; Splenomegaly; Thrombelastography; Thromboc | 1957 |
[HIGH PLATELET LEVEL DISCOVERED AFTER SPLENECTOMY AND TREATED WITH MYLERAN].
Topics: Blood Platelets; Busulfan; Hemostasis; Humans; Splenectomy; Thrombocytosis | 1964 |
PRIMARY THROMBOCYTHEMIA: A SURGICAL PARADOX. REPORT OF A CASE.
Topics: Blood Platelets; Busulfan; Cell Count; Drug Therapy; Hemorrhagic Disorders; Humans; Hyperplasia; Meg | 1964 |
[HEMORRHAGIC THROMBOCYTHEMIA AND THE "MYELOPROLIFERATIVE SYNDROME"].
Topics: Anemia; Anemia, Hypochromic; Blood Platelets; Busulfan; Gastrointestinal Hemorrhage; Hemorrhage; Hem | 1964 |
[HEMORRHAGIC THROMBOCYTHEMIA].
Topics: Blood Platelet Disorders; Blood Platelets; Busulfan; Hemorrhagic Disorders; Humans; Phospholipids; R | 1964 |
PORPHYRIA CUTANEA TARDA ASSOCIATED WITH REFRACTORY ANEMIA (INEFFECTIVE ERYTHROPOIESIS) AND THROMBOCYTHEMIA.
Topics: Anemia; Anemia, Refractory; Blood Platelet Disorders; Blood Platelets; Busulfan; Chromium Isotopes; | 1964 |
[ON THROMBOCYTOSIS IN CHILDREN].
Topics: Blood Platelets; Busulfan; Child; Drug Therapy; Leukemia; Leukemia, Myeloid; Thrombocytosis; Toxicol | 1964 |
Safety profile of hydroxyurea in the treatment of patients with Philadelphia-negative chronic myeloproliferative disorders.
Topics: Adult; Aged; Aged, 80 and over; Busulfan; Enzyme Inhibitors; Female; Humans; Hydroxyurea; Leukemia, | 2005 |
Focal nodular hyperplasia after busulfan treatment.
Topics: Busulfan; Female; Focal Nodular Hyperplasia; Humans; Immunosuppressive Agents; Middle Aged; Thromboc | 2005 |
Alteration of platelets and virus-like particles by busulfan in myeloproliferative disorders.
Topics: Blood Platelets; Busulfan; Humans; Leukemia, Myeloid; Myeloproliferative Disorders; Polycythemia Ver | 1980 |
[Megakaryocytic pseudomyelosis with severe thrombocytosis].
Topics: Aged; Alkaline Phosphatase; Alpha-Globulins; Busulfan; Female; Humans; Leucyl Aminopeptidase; Liver; | 1981 |
[Essential thrombocythemia. Clinical, biological study and developmental study of 61 cases].
Topics: Busulfan; Female; Hematologic Tests; Humans; Hydroxyurea; Male; Middle Aged; Phosphorus Radioisotope | 1984 |
1-(2-Chloroethyl)-cyclohexyl-nitrosourea-induced remission in essential thrombocythemia.
Topics: Adult; Age Factors; Aged; Alkylating Agents; Busulfan; Female; Humans; Leukemia, Myeloid, Acute; Lom | 1983 |
[Long-term treatment of thrombocytosis and thrombocythemia].
Topics: Busulfan; Humans; Myeloproliferative Disorders; Pyrimethamine; Thrombocythemia, Essential; Thrombocy | 1980 |
Primary thrombocythemia in a child.
Topics: Adolescent; Busulfan; Child; Humans; Male; Splenomegaly; Thrombocytosis | 1980 |
Essential thrombocythaemia.
Topics: Adult; Aged; Blood Platelets; Bone Marrow; Busulfan; Female; Humans; Male; Megakaryocytes; Platelet | 1980 |
Survival and risk of leukaemia in polycythaemia vera and essential thrombocythaemia treated with oral radiophosphorus: are safer drugs available?
Topics: Administration, Oral; Aged; Busulfan; Female; Humans; Hydroxyurea; Leukemia, Myeloid, Acute; Leukemi | 1995 |
Combined plateletpheresis and cytotoxic chemotherapy for symptomatic thrombocytosis in myeloproliferative disorders.
Topics: Adult; Aged; Aged, 80 and over; Busulfan; Combined Modality Therapy; Cytarabine; Drug Therapy, Combi | 1993 |
[Radioactive phosphorus (32P); an old but not bad treatment for polycythemia vera].
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents, Alkylating; Busulfan; Female; Humans; Leukemi | 1996 |
The microvasculature in myeloproliferative disease. A study using retinal fluorescein angiography.
Topics: Adult; Aged; Aged, 80 and over; Allergens; Antineoplastic Agents; Arterial Occlusive Diseases; Aspir | 1996 |
Successful pregnancies after recurrent abortions in mild essential thrombocythemia.
Topics: Abortion, Habitual; Adult; Aspirin; Busulfan; Female; Humans; Platelet Aggregation Inhibitors; Pregn | 1998 |
Development of erythrocytosis in the course of essential thrombocythemia.
Topics: Adult; Aged; Aged, 80 and over; Busulfan; Female; Follow-Up Studies; Hematocrit; Hemoglobins; Humans | 1999 |
Effect of busulfan on oncornavirus-like activity in platelets and chromosomes in polycythemia vera and essential thrombocythemia.
Topics: Aged; Aneuploidy; Blood Cell Count; Blood Platelets; Busulfan; Chromosomes; Female; Humans; Oncogeni | 1977 |
A hitherto undescribed defect of platelet coagulant activity in polycythaemia vera and essential thrombocythaemia.
Topics: Adult; Aged; Blood Coagulation; Blood Platelets; Busulfan; Factor V; Factor X; Female; Humans; Male; | 1979 |
Microvascular occlusive lesions in primary thrombocythaemia.
Topics: Adult; Aged; Busulfan; Capillaries; Diagnosis, Differential; Female; Gangrene; Humans; Ischemia; Mal | 1977 |
Gangrene of toes with normal peripheral pulses.
Topics: Adult; Aged; Amputation, Surgical; Arteriosclerosis; Busulfan; Collateral Circulation; Diabetic Angi | 1977 |
Hydroxyurea in the management of the hematologic complications of chronic granulocytic leukemia.
Topics: Busulfan; Humans; Hydroxyurea; Leukemia, Myeloid; Leukocyte Count; Leukocytosis; Mitobronitol; Splen | 1975 |
[The treatment of myeloproliferative syndromes].
Topics: Aged; Bloodletting; Busulfan; Chlorambucil; Female; Humans; Leukemia, Myeloid; Male; Myeloproliferat | 1975 |
Chronic myelocytic leukemia and the myeloproliferative diseases during the child-bearing years.
Topics: Aged; Busulfan; Child; Female; Humans; Leukemia, Myeloid; Male; Middle Aged; Myeloproliferative Diso | 1976 |
Erythroleukemia-like syndrome due to busulfan toxicity in polycythemia vera.
Topics: Adult; Bone Marrow; Bone Marrow Diseases; Busulfan; Female; Humans; Leukemia, Erythroblastic, Acute; | 1976 |
Treatment of basophilic leukemia in a dog.
Topics: Animals; Basophils; Bone Marrow; Bone Marrow Cells; Busulfan; Dog Diseases; Dogs; Erythrocyte Count; | 1975 |
[A patient with primary thrombocythemia].
Topics: Busulfan; Diagnosis, Differential; Female; Humans; Middle Aged; Thrombocytosis | 1985 |
[Vaquez's diseas. Clinical and developmental study. Apropos of 144 cases].
Topics: Adult; Arteriosclerosis; Arteritis; Blood Sedimentation; Busulfan; Child; Erythrocyte Count; Female; | 1968 |
Thrombocythaemia. Familial occurrence and transition into blastic crisis.
Topics: Alkaline Phosphatase; Anemia, Aplastic; Blood Coagulation Tests; Bone Marrow Examination; Busulfan; | 1974 |
[A new etiology of inflammatory livedo: thrombocytosis].
Topics: Arteritis; Busulfan; Diagnosis, Differential; Erythromelalgia; Female; Foot Dermatoses; Humans; Hydr | 1969 |
Blood and neoplastic diseases. Myeloproliferative disorders.
Topics: Adrenal Cortex Hormones; Androgens; Blood Transfusion; Bloodletting; Busulfan; Chlorambucil; Cycloph | 1974 |
Platelet defects in the myeloproliferative disorders.
Topics: Adenosine Diphosphate; Adult; Aged; Blood Coagulation Tests; Blood Platelets; Busulfan; Densitometry | 1972 |
Thrombocytosis in chronic granulocytic leukemia: incidence and clinical significance.
Topics: Anemia; Azauridine; Blood Cell Count; Blood Platelets; Bone Marrow Examination; Busulfan; Cell Trans | 1974 |
Thrombocytosis. A source of increased bleeding tendency.
Topics: Aged; Blood Cell Count; Blood Platelets; Busulfan; Carcinoma; Colon, Sigmoid; Colonic Neoplasms; Div | 1973 |
Metabolism of human prothrombin and fibrinogen in patients with thrombocytosis secondary to myeloproliferative states.
Topics: Adolescent; Adult; Aged; Alkaline Phosphatase; Blood Cell Count; Blood Coagulation Factors; Blood Co | 1973 |
Upper extremity venous thrombosis with pulmonary embolism. A complication of excretory urography.
Topics: Arm; Axillary Vein; Busulfan; Contrast Media; Diatrizoate; Humans; Iothalamic Acid; Male; Middle Age | 1974 |
Platelet defects in post-splenectomy thrombocythaemia.
Topics: Adenosine Diphosphate; Adult; Blood Coagulation Factors; Blood Platelet Disorders; Busulfan; Collage | 1971 |
[Chronic myelogenous leukemia. Results of therapy with busulfan].
Topics: Adult; Age Factors; Aged; Ambulatory Care; Blood Transfusion; Busulfan; Chronic Disease; Female; Fol | 1969 |
Uracil mustard in the treatment of thrombocythemia.
Topics: Blood Cell Count; Blood Platelets; Bone Marrow Examination; Busulfan; Coronary Disease; Electrocardi | 1970 |
[Treatment of chronic myeloid leukemia with dibromomannitol].
Topics: Adult; Bromides; Busulfan; Female; Humans; Leukemia, Myeloid; Leukocytosis; Male; Mannitol; Melanosi | 1970 |
The effect of vincristine on the platelet count in rats.
Topics: Animals; Blood Cell Count; Blood Platelets; Bone Marrow; Bone Marrow Cells; Busulfan; Megakaryocytes | 1970 |
Polycythaemia vera: differential diagnosis by ferrokinetic studies and treatment with busulphan (Myleran).
Topics: Blood Cell Count; Blood Platelets; Bone Marrow Examination; Busulfan; Diagnosis, Differential; Eryth | 1968 |
Thrombocytosis in chronic inflammatory bowel disease.
Topics: Adolescent; Adult; Blood Cell Count; Blood Platelets; Bone Marrow Cells; Busulfan; Chronic Disease; | 1968 |
Idiopathic thrombocytosis. A treatable cause of transient ischemic attacks.
Topics: Adult; Blood Platelet Disorders; Busulfan; Female; Hemorrhage; Humans; Hyperplasia; Ischemic Attack, | 1968 |
Metabolic fate of tritiated busulfan in man.
Topics: Bone Marrow Diseases; Busulfan; Humans; Leukemia, Lymphoid; Lung Neoplasms; Metabolic Clearance Rate | 1969 |
Treatment of symptomatic thrombocythemia.
Topics: Busulfan; Chlorambucil; Dipyridamole; Female; Heparin; Humans; Mesenteric Vascular Occlusion; Middle | 1969 |
Thrombocytopheresis: a rapid and effective approach to symptomatic thrombocytosis.
Topics: Aged; Busulfan; Female; Humans; Immunization, Passive; Male; Middle Aged; Nitrogen Mustard Compounds | 1966 |
Thrombocytosis with impaired platelet adhesiveness and platelet factor 3 availability.
Topics: Blood Platelet Disorders; Busulfan; Child; Female; Hemostasis; Humans; Thrombocytosis | 1966 |